CYT387
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CYT387, covering 2019-02-04 to 2019-02-04. Get the full timeline:
Most recent: Clinical Trial Update: Extension Study Evaluating the Long Term Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET) [Phase 2]